• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison.

作者信息

Pagliarello Calogero, Girardelli Carlo Renè

机构信息

Division of Dermatology, UO Multizonale APSS, Alopecia Areata Outpatient Service, Trento, Italy.

出版信息

JAAD Case Rep. 2025 Jun 16;62:107-109. doi: 10.1016/j.jdcr.2025.05.024. eCollection 2025 Aug.

DOI:10.1016/j.jdcr.2025.05.024
PMID:40718673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296489/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b1/12296489/5d84a5fa7d3f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b1/12296489/5d84a5fa7d3f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67b1/12296489/5d84a5fa7d3f/gr1.jpg

相似文献

1
Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison.
JAAD Case Rep. 2025 Jun 16;62:107-109. doi: 10.1016/j.jdcr.2025.05.024. eCollection 2025 Aug.
2
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment.在两项III期试验中，巴瑞替尼治疗重度斑秃成人患者长达4年（中位治疗时间2.3年）的安全性。
Am J Clin Dermatol. 2025 Apr 11. doi: 10.1007/s40257-025-00932-0.
3
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.斑秃患者眉毛和睫毛受累情况及巴瑞替尼治疗反应的研究
Br J Dermatol. 2025 Apr 3. doi: 10.1093/bjd/ljaf088.
4
Treatments for alopecia areata: a network meta-analysis.斑秃治疗方法的网状荟萃分析。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2.
5
Interventions for alopecia areata.斑秃的干预措施。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD004413. doi: 10.1002/14651858.CD004413.pub2.
6
Local Corticosteroids for Alopecia Areata: A Narrative Review.局部使用皮质类固醇治疗斑秃：一项叙述性综述
Dermatol Ther (Heidelb). 2025 May 5. doi: 10.1007/s13555-025-01421-2.
7
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.口服酪氨酸激酶3/肝细胞癌中表达的酪氨酸激酶家族激酶抑制剂芦可替尼24个月的疗效和安全性：斑秃的ALLEGRO IIb/III期和长期III期临床研究的综合分析
Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365.
8
Effectiveness and safety of baricitinib in patients with alopecia areata: a systematic review and Meta-analysis of randomized controlled trials.巴瑞替尼治疗斑秃患者的有效性和安全性：一项随机对照试验的系统评价和Meta分析
Curr Med Res Opin. 2023 Feb;39(2):249-257. doi: 10.1080/03007995.2022.2135838. Epub 2022 Oct 22.
9
Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.最初接受4毫克巴瑞替尼治疗的重度头皮斑秃患者减量滴定的结果：来自BRAVE-AA2研究的第152周数据。
J Am Acad Dermatol. 2025 Feb;92(2):299-306. doi: 10.1016/j.jaad.2024.09.072. Epub 2024 Oct 22.
10
Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study.巴瑞替尼与传统疗法治疗重度斑秃的疗效和安全性比较：一项回顾性队列研究
J Cosmet Dermatol. 2025 Feb;24(2):e16666. doi: 10.1111/jocd.16666. Epub 2024 Nov 20.

本文引用的文献

1
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience.巴瑞替尼治疗重度斑秃患者的有效性和安全性：一项为期36周的多中心真实世界研究经验
J Dermatolog Treat. 2023 Dec;34(1):2268764. doi: 10.1080/09546634.2023.2268764. Epub 2023 Oct 11.
2
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.在接受巴瑞替尼治疗严重斑秃期间何时可以期待头发生长：两项 III 期临床试验中患者轨迹分析的结果。
Br J Dermatol. 2023 Nov 16;189(6):666-673. doi: 10.1093/bjd/ljad253.
3
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series.
巴瑞替尼联合小剂量皮质类固醇治疗严重斑秃患者的疗效显著改善：八例病例系列。
Clin Exp Dermatol. 2023 Oct 25;48(11):1258-1259. doi: 10.1093/ced/llad239.
4
Tachyphylaxis to topical glucocorticoids; what is the evidence?局部用糖皮质激素的快速耐受现象；证据有哪些？
Dermatol Online J. 2013 Jul 14;19(7):18954.
5
Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.银屑病患者对局部应用类固醇未表现出治疗快速耐受现象。
J Am Acad Dermatol. 1999 Oct;41(4):546-9.
6
Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.在正常皮肤与巴豆油诱导的皮炎皮肤中，局部应用0.05%丙酸氯倍他索对组胺诱导的风团抑制的快速耐受性。
Dermatology. 1996;193(2):121-3. doi: 10.1159/000246225.
7
Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis.
Arch Dermatol. 1982 May;118(5):305-8. doi: 10.1001/archderm.118.5.305.